A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension

AIMS: The aim was to compare efficacy and cost-effectiveness of bimatoprost 0.03% and brimonidine 0.2% in primary open-angle glaucoma (POAG)/ocular hypertension (OHT). SETTINGS AND DESIGN: Open, randomized, cross-over, comparative study. MATERIALS AND METHODS: Forty patients of POAG or OHT with intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Natt, Navreet Kaur, Gupta, A, Singh, G, Singh, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313493/
https://www.ncbi.nlm.nih.gov/pubmed/25579357
http://dx.doi.org/10.4103/0301-4738.149134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313493/
https://www.ncbi.nlm.nih.gov/pubmed/25579357
http://dx.doi.org/10.4103/0301-4738.149134

Ejemplares similares